The company will use the new funds to expand Health Catalyst’s technology and services offerings, including the Health Catalyst Data Operating System, a data warehouse and application development platform. It will also support the company’s “expansion, already underway, into the life sciences and international markets,” said Health Catalyst CEO Dan Burton.
OrbiMed, a healthcare public and private market investment firm, led the equity and debt funding round. Other investors were Sequoia Capital, UPMC Enterprises and Kaiser Permanente Ventures.
More articles on health IT:
Epic named ‘Best in KLAS’ overall software suite for 9th straight year
How ‘big tech’ fared last quarter: Earnings from Amazon, Google, Apple & more
Former ONC chief Dr. Karen DeSalvo to advise digital health investment firm: 4 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
